Orally active 3-(3-pyridyl)pyrazolo[1,5-a]pyrimidines as nonpeptide CRF1 receptor antagonists.

被引：0

作者：

Chen, C ^{[1
]}

Wilcoxen, K ^{[1
]}

Bozigian, H ^{[1
]}

Chen, T ^{[1
]}

Cha, M ^{[1
]}

McCarthy, JR ^{[1
]}

Huang, CQ ^{[1
]}

Haddach, M ^{[1
]}

Zhu, YF ^{[1
]}

Murphy, B ^{[1
]}

De Souza, EB ^{[1
]}

Grigoriadis, DE ^{[1
]}

机构：

[1] Neurocrine Biosci Inc, San Diego, CA 92121 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

214-MEDI

引用

页码：U38 / U38

页数：1

共 50 条

[21] Synthesis and SAR of 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines as potent serotonin 5-HT6 receptor antagonists
Ivachtchenko, Alexandre V.
Golovina, Elena S.
Kadieva, Madina G.
Kysil, Volodymyr M.
Mitkin, Oleg D.
Tkachenko, Sergey E.
Okun, Ilya
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (04) : 1482 - 1491
[22] Pyrazolo[1,5-a]pyrimidines.: Identification of the privileged structure and combinatorial synthesis of 3-(hetero)arylpyrazolo[1,5-a]pyrimidine-6-carboxamides
Gregg, Brian T.
Tymoshenko, Dmytro O.
Razzano, Dana A.
Johnson, Matthew R.
JOURNAL OF COMBINATORIAL CHEMISTRY, 2007, 9 (03): : 507 - 512
[23] SYNTHESIS AND EVALUATION OF NOVEL PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
KIYAMA, R
HAYASHI, K
HARA, M
FUJIMOTO, M
KAWABATA, T
KAWAKAMI, M
NAKAJIMA, S
FUJISHITA, T
CHEMICAL & PHARMACEUTICAL BULLETIN, 1995, 43 (06) : 960 - 965
[24] Heterocyclic triazolopyridines and triazolopyrimidines as corticotropin releasing factor (CRF1) receptor antagonists.
Arvanitis, AG
Bakthavatchalam, R
Beck, JP
Rescinito, JT
Arnold, CR
Zaczek, R
Gilligan, PJ
Olson, RE
Robertson, DW
Fitzgerald, LW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U948 - U949
[25] Studies on activated nitriles: Synthesis of new 3-cyano-(p-antipyrylamino)-pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]triazines
Fathalla, OA
Zaki, MEA
INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 1998, 37 (05): : 484 - 490
[26] New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck
Gommermann, Nina
Buehlmayer, Peter
von Matt, Anette
Breitenstein, Werner
Masuya, Keiichi
Pirard, Bernard
Furet, Pascal
Cowan-Jacob, Sandra W.
Weckbecker, Gisbert
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3628 - 3631
[27] THIENO[2',3'/3,4]PYRAZOLO[1,5-A]PYRIMIDINES AND THIENO[2',3'/3,4]PYRAZOLO[1,5-A]TRIAZINES - SYNTHESIS OF THE NOVEL RING-SYSTEMS
BRIEL, D
PHARMAZIE, 1995, 50 (10): : 675 - 678
[28] Discovery of orally active vitronectin receptor (αvβ3) antagonists.
Heerding, DA
Miller, WH
Willette, R
Yue, TL
Lark, M
Stroup, G
Badger, A
Ohlstein, E
Gowen, M
Huffman, WF
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U567 - U568
[29] Synthesis of cycloalkane-annelated 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines and their evaluation as 5-HT6 receptor antagonists
Ivachtchenko, Alexandre V.
Dmitriev, Dmitri E.
Golovina, Elena S.
Dubrovskaya, Elena S.
Kadieva, Madina G.
Koryakova, Angela G.
Kysil, Volodymyr M.
Mitkin, Oleg D.
Tkachenko, Sergey E.
Okun, Ilya M.
Vorobiov, Anton A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2133 - 2136
[30] REACTIONS WITH 3,5-DIAMINOPYRAZOLES - NEW ROUTES TO PYRAZOLO[1,5-A]PYRIMIDINES
ELGEMEIE, GEH
FATHY, NM
FADDAH, LM
EBEID, MY
ELSAID, MK
ARCHIV DER PHARMAZIE, 1991, 324 (03) : 149 - 152

← 1 2 3 4 5 →